The use of probiotics in pediatric practice
https://doi.org/10.21518/2079-701X-2020-10-55-63
Abstract
Human microbiota takes part in various physiological processes of the body, and violation of its qualitative and quantitative composition is associated with the development of several diseases. Microbiota and macroorganism coexist in a kind of symbiosis, where each partner benefits from each other and affects the other. The effects of microbiota are manifested both locally and on a systemic level. The function of the microbiota to maintain homeostasis is comparable to that of any other vital organ, so any disturbance of its composition can lead to deviations in the state of human health. The article deals with ways of correction of intestinal microbiota disturbances with the help of probiotic preparations. The urgency of the problem is caused by the abundance of probiotic preparations offered at the pharmaceutical market and insufficient knowledge about them in large studies involving children. The article presents the requirements for efficacy and safety of probiotic strains both included in preparations and having the status of biologically active additives, including those used in pediatrics. Data on the role of both probiotics as a whole and individual strains in the prevention and treatment of digestive tract diseases in children are presented. The effectiveness of the most studied probiotic strains, in particular Lactobacillis rhamnosus GG, in therapeutic schemes and in the prevention of gastrointestinal diseases in children, in particular in the treatment of acute gastroenteritis, antibiotic-associated diarrhea and functional abdominal pain, is analyzed.
About the Authors
N. L. Pakhomovskaia
National Medical Research Center for Children’s Health
Russian Federation
Russian Federation
Nadezhda L. Pakhomovskaia, Cand. of Sci. (Med.), gastroenterologist of the Advisory Department of the Consultative and Diagnostic Centre
2, Bldg. 1, Lomonosovskiy Prospect, Moscow, 119926
O. F. Tatyanina
National Medical Research Center for Children’s Health
Russian Federation
Russian Federation
Olga F. Tatyanina, Cand. of Sci. (Med.), gastroenterologist of the Advisory Department of the Consultative and Diagnostic Centre
2, Bldg. 1, Lomonosovskiy Prospect, Moscow, 119926
References
1. Sender R., Fuchs S., Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016;14(8):e1002533. doi: 10.1371/journal.pbio.1002533.
2. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C. et al. A human gut microbial gene catalog established by metagenomic sequencing. Nature. 2010;464(7285):59–65. Available at: https://www.nature.com/articles/nature08821.
3. Bindels L., Delzenne N., Cani P., Walter J. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol. 2015;12:303–310. doi: 10.1038/nrgastro.2015.47.
4. Landman C., Quévrain E. Gut microbiota: Description, role and pathophysiologic implications. La Rev Méd Interne. 2016;37(6):418–423. doi: 10.1016/j.revmed.2015.12.012.
5. Floch M.H., Walker W.A., Sanders M.E., Nieuwdorp M., Kim A.S., Brenner D.A. et al. Recommendations for probiotic use – 2015 update: proceedings and consensus opinion. J Clin Gastroenterol. 2015;49:69–73. doi: 10.1097/MCG.0000000000000420.
6. Cresci G., Bawden E. The Gut Microbiome: What we do and don’t know. Nutr Clin Pract. 2015;30(6):734–746. doi: 10.1177/0884533615609899.
7. Pakhomovskaya N.L., Venediktova М.M. Healthy intestinal colonization in children: strong immunity. Meditsinskiy sovet = Medical Council. 2018;(17):199–206. (In Russ.) doi: 10.21518/2079-701X-2018-17-199-205.
8. Vangay P., Ward T., Gerber J.S., Knights D. Antibiotics, pediatric dysbiosis and disease. Cell Host Microbe. 2015;17(5):553–564. doi: 10.1016/j.chom.2015.04.006.
9. Guarner F., Sander М.Е., Rami E., Fedorak R., Gangl A., Garisch J. et al. Probiotics and prebiotics. 2017. Available at: http://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english.
10. Min Y.W., Rhee P.L. The Role of Microbiota on the Gut Immunology. Clin Ther. 2015;37(5):968–975. doi: 10.1016/j.clinthera.2015.03.009.
11. Gensollen T., Iyer S., Kasper D.L., Blumberg R.S. How colonization by microbiota in early life shapes the immune system. Science. 2016;352(6285):539–544. doi: 10.1126/science.aad9378.
12. Drozdov V.N., Vorobeva O.A., Astapovsky A.A., Shikh E.V. Probiotics in Pediatrics: How to Choose Effective and Safety Specimen for a Child. Current Pediatrics. 2019;18(4):277284. (In Russ.) doi: 10.15690/vsp.v18i4.2045.
13. Araya M., Morelli L., Reid M.E., Stanton C. Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada, April 30 and May 1, 2002. Available at: https://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf.
14. Herman L., Chemaly M., Cocconcelli P.S., Fernandez P., Kllein G., Piexe L. et al. The qualified presumption of safety assessment and its role in EFSA risk evaluations: 15 years past. FEMS Microbiol Lett. 2019;366(1). doi: 10.1093/femsle/fny260.
15. Saavedra J.M. Clinical applications of probiotic agents. Am J Clin Nutr. 2001;73(6):1147–1151. doi: 10.1093/ajcn/73.6.1147S.
16. Batchelor H.K., Marriott J.F. Pediatric pharmacokinetics: key considerations. Br J Clin Pharmacol. 2015;79(3):395–404. doi: 10.1111/bcp.12267.
17. Lebeer S., Claes I., Tytgat H.L., Verhoeven T.L.A., Marien E., von Ossowski I. et al. Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl Environ Microbiol. 2012;78(1):185–193. doi: 10.1128%2FAEM.06192-11.
18. Belmer S.V., Karpina L.M. Formation of intestinal biocenosis in infants and the ways of its correction. Current Pediatrics. 2010;9(4):138–142. (In Russ.) Available at: https://vsp.spr-journal.ru/jour/article/view/933?locale=ru_RU.
19. Cruchet S., Furnes R., Maruy A., Hebel E., Palacios J., Medina F. et al. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. Pediatr Drugs. 2015;17(3):199–216. doi: 10.1007/s40272-015-0124-6.
20. Zakharova I.N., Borzova E.Y., Simakova M.A. Lactobacillus rhamnosus GG: experience in pediatric gastroenterology. Rossiyskiy Vestnik Perinatologii i Pediatrii = Russian Bulletin of Perinatology and Pediatrics. 2019;64(6):20–29. (In Russ.) doi: 10.21508/1027-4065-2019-64-6-20-29.
21. Capurso L. Thirty Years of Lactobacillus rhamnosus GG. J Clin Gastroenterol. 2019;53:1–41. doi: 10.1097/MCG.0000000000001170.
22. Segers M.E., Lebeer S. Towards a better understanding of Lactobacillus rhamnosus GG – host interactions. Microb Cell Fact. 2014;13:7. doi: 10.1186/1475-2859-13-S1-S7.
23. Pace F., Pace M., Quartarone G. Probiotics in digestive diseases: focus on Lactobacillus GG. Minerva Gastroenterol Dietol. 2015;61(4):273–292. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26657927.
24. Lu R., Fasano S., Madayiputhiya N., Morin N.P., Nataro J., Fasano A. Isolation, Identification, and Characterization of Small Bioactive Peptides From Lactobacillus GG Conditional Media That Exert Both Anti-Gramnegative and Gram-positive Bactericidal Activity. J Pediatr Gastroenterol Nutr. 2009;49(1):23–30. doi: 10.1097/MPG.0b013e3181924d1e.
25. Oganezova I.A. Intestinal microbiota and immunity: immunomodulatory effects of Lactobacillus rhamnosus GG. RMZH = RMJ. 2018;(9):39–44. (In Russ.) Available at: https://www.rmj.ru/articles/pediatriya/Kishechnaya_mikrobiota_iimmunitet_immunomoduliruyuschie_effekty_Lactobacillus_rhamnosus_GG.
26. Yan F., Polk D.B. Lactobacillus rhamnosus GG: An Updated Strategy to Use Microbial Products to Promote Health. Funct Food Rev. 2012;4(2):77–84. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006995.
27. Wang Y., Liu L., Moore D.J., Shen X., Peek R.M., Acra S.A. et al. An LGGderived protein promotes IgA production through up-regulation of APRIL expression in intestinal epithelial cells. Mucosal Immunol. 2017;10:373–384. doi: 10.1038/mi.2016.57.
28. Li N., Russell W.M., Douglas-Escobar M., Hauser N., Lopez M., Neu J. Live and heat-killed Lactobacillus rhamnosus GG: effects on proinflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats. Pediatr Res. 2009;66(2):203–207. doi: 10.1203/PDR.0b013e3181aabd4f.
29. Mu C., Yang Y., Zhu W. Crosstalk Between The Immune Receptors and Gut Microbiota. Curr Protein And Pept Sci. 2015;16(7):622–631. Available at: https://www.researchgate.net/deref/http%3A%2F%2Fdx.doi.org%2F10.2174%2F1389203716666150630134356.
30. Maranduba C.M. da C., De Castro S.B.R., de Souza G.T., Rossato С., da Guia F.C., Valente M.A.S. et al. Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis J Immunol Res. 2015;2015:931574. doi: 10.1155/2015/931574.
31. Belkaid Y., Harrison O. J. Homeostatic immunity and the microbiota. Immunity. 2017;46(4):562–576. doi: 10.1016/j.immuni.2017.04.008.
32. Gury-BenAri M., Thaiss C.F., Serafini N., Santo J., Elinav E., Amit I. et al. The Spectrum and Regulatory Landscape of Intestinal Innate Lymphoid Cells Are Shaped by the Microbiome. Cell. 2016;166(5):1231–1246. doi: 10.1016/j.cell.2016.07.043.
33. Guarino A., Ashkenazi S., Gendrel D., Lo Vecchio A., Shamir R., Szajewska H. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidencebased guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr. 2014;59(1):132–152. doi: 10.1097/MPG.0000000000000375.
34. Guarino A., Guandalini S., Lo Vecchio A. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol. 2015;49:37–45. doi: 10.1097/MCG.0000000000000349.
35. Vandenplas Y. Probiotics and prebiotics in infectious gastroenteritis. Best Pract Res Clin Gastroenterol. 2016;30(1):49–53. doi: 10.1016/j.bpg.2015.12.002.
36. Blaabjerg S., Artzi D.M., Aabenhus R. Probiotics for the prevention of antibiotic-associated diarrhea in outpatients – a systematic review and metaanalysis. Antibiotics. 2017;6(4):21. doi: 10.3390/antibiotics6040021.
37. McFarland L.V., Ozen M., Dinleyici E.C., Goh S. Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections. World J Gastroenterol. 2016;22(11):3078–3104. doi: 10.3748/wjg.v22.i11.3078.
38. Zakharova I.N., Berezgnaya I.V., Sugyan N.G. Antibiotic-associated diarrheain children: what is new? Meditsinskii sovet = Medical Council. 2017;(19):126–133. (In Russ.) doi: 10.21518/2079-701X-2017-19-126-133.
39. Czepiel J., Dróżdż M., Pituch H., Kuijper E.J., Perucki W., Mielimonka A. et al. Clostridium difficile infection: review. Eur J Clin Microbiol Infect Dis. 2019;38(7):1211–1221. doi: 10.1007/s10096-019-03539-6.
40. Perceval C., Szajewska H., Indrio F., Weizman Z., Vandenplas Y. Prophylactic use of probiotics for gastrointestinal disorders in children. Lancet Child Adolesc Health. 2019;3(9):655–662. doi: 10.1016/S2352-4642(19)30182-8.
41. Szajewska H., Kołodziej M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther. 2015;42(10):1149–1157. doi: 10.1111/apt.13404.
42. Goldenberg J.Z., Lytvyn L., Steurich J., Parkin P., Mahant S., Johnston B.C. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2015;(12):CD004827. doi: 10.1002/14651858.CD004827.pub4.
43. Szajewska H., Canani R.B., Guarino A., Hojsak I., Indrio F., Kolacek S. et al. Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children. J Pediatr Gastroenterol Nutr. 2016;62(3):495–506. doi: 10.1097/MPG.0000000000001081.
44. Guo Q., Goldenberg J.Z., Humphrey C., El Dib R., Johnston B.C. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2019;(4):CD004827. doi: 10.1002/14651858.CD004827.pub5.
45. Liu H.N., Wu H., Chen Y.Z., Chen Y.J., Shen X.Z., Liu T.T. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: a systematic review and meta-analysis. Dig Liver Dis. 2017;49(4):331–337. doi: 10.1016/j.dld.2017.01.142.
46. Korterink J., Devanarayana N.M., Rajindrajith S., Vlieger A., Benninga M.A. Childhood functional abdominal pain: mechanisms and management. Nat Rev Gastroenterol Hepatol. 2015;12(3):159–171. doi: 10.1038/nrgastro.2015.21.
47. Andreyeva I.V. Evidence-based data on effectiveness of Lactobacillus rhamnosus GG and Bifidobacterium lactis ВB-12 in pediatric practice. Voprosy sovremennoi pediatrii = Current Pediatrics. 2011;10(1):50–57. (In Russ.) Available at: https://vsp.spr-journal.ru/jour/article/view/539/466.
Review
For citations:
Pakhomovskaia NL, Tatyanina OF. The use of probiotics in pediatric practice. Meditsinskiy sovet = Medical Council. 2020;(10):55-63. (In Russ.) https://doi.org/10.21518/2079-701X-2020-10-55-63
Views:
532
Email this article 